David Nelson, M.D.

Assistant Professor

School: Medical School
Department: Cardiovascular & Thoracic Surgery

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

Education

Undergraduate School: Vanderbilt University (2008)
Medical School: Northwestern Univ.-Feinberg School of Medicine (2013)
Internship: Beth Israel Deaconess Medical Center (2014)
Graduate School: University of Texas Health Science Center at Houston (2018)
Clinical Research Fellowship: University of Texas MD Anderson Cancer Center (2018)
Residency: Loma Linda University Medical Center (2021)
Other Post Graduate Training: University of Texas MD Anderson Cancer Center (2023)

Publications

Featured Publications

Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities.: Nelson DB, Mitchell KG, Wang J, Fujimoto J, Godoy M, Behrens C, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Swisher SG, Moran CA, Kalhor N, Weissferdt A, Wistuba II, Roth JA, Antonoff MB, J Thorac Dis 2020 Mar 12 3 329-337
Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer.: Nelson DB, Niu J, Mitchell KG, Antonoff MB, Giordano SH, Hofstetter WL, Vaporciyan AA, Sepesi B, Mehran RJ, Rice DC, J Thorac Cardiovasc Surg 2020 Feb 159 2 691-702.e5
Commentary: Revisiting old data: Is video-assisted thoracoscopic surgery still superior to thoracotomy when enhanced recovery is applied?: Nelson DB, Antonoff MB, J Thorac Cardiovasc Surg 2020 Jan 159 1 297-298
Persistent Opioid Use Among the Elderly After Lung Resection: A SEER-Medicare Study.: Nelson DB, Niu J, Mitchell KG, Sepesi B, Hofstetter WL, Antonoff MB, Giordano SH, Mehran RJ, Rice DC, Ann Thorac Surg 2020 Jan 109 1 194-202
Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization.: Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG, Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MB, Innovations (Phila) 2020 15 1 57-65
Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?: Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Blum M, Hofstetter WL, Dis Esophagus 2019 Dec 32 10 1-6
Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases.: Nelson DB, Tayob N, Nguyen QN, Erasmus J, Mitchell KG, Hofstetter WL, Sepesi B, Antonoff MB, Mehran RJ, J Thorac Cardiovasc Surg 2019 Oct 158 4 1234-1241.e16
Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer.: Nelson DB, Cata JP, Niu J, Mitchell KG, Vaporciyan AA, Antonoff MB, Hofstetter WL, Giordano SH, Sepesi B, Mehran RJ, Rice DC, Pain 2019 Oct 160 10 2365-2373
Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer.: Mitchell KG, Parra ER, Nelson DB, Zhang J, Wistuba II, Fujimoto J, Roth JA, Antonoff MB, J Thorac Cardiovasc Surg 2019 Sep 158 3 911-919.e6
Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.: Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL, Ann Thorac Surg 2019 Sep 108 3 845-851